Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Bioaegis Therapeutics Inc.

Clinical trials sponsored by Bioaegis Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New drug aims to reduce deaths from severe lung failure Results expected Oct 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet finished but already full! 1
Sort by
  • New drug aims to reduce deaths from severe lung failure

    Disease control Recruiting now

    This study tests an experimental drug called recombinant human plasma gelsolin (rhu-pGSN) added to standard care for people with moderate-to-severe acute respiratory distress syndrome (ARDS) caused by pneumonia or other infections. About 600 hospitalized adults will receive eithe…

    Phase 2 • Sponsor: BioAegis Therapeutics Inc. • Aim: Disease control

    Last updated Jun 27, 2026 14:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space